Phase 2 Study of Yimitasvir Phosphate Capsules

Clinical trial NCT03458481 · COMPLETED

Trial details

NCT number: NCT03458481
Sponsor: Sunshine Lake Pharma Co., Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic HCV Infection

Start date: 2017-07-31
Primary completion: 2018-05-08
Enrollment: 129

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.